This content is machine translated Multiple sclerosis Multiple sclerosis 2025: New strategies against progression and the role of microglia The treatment of multiple sclerosis has made enormous progress thanks to highly effective disease-modifying therapies, in particular anti-CD20 antibodies. For most newly diagnosed patients, a life without disability is realistic....…
View Post 4 min Education Geriatrics Neurology Pharmacology and toxicology RX Studies Opicapon: double benefit for motor function and sleep in Parkinson’s disease Sleep disorders are among the most common non-motor Parkinson’s symptoms. The targeted treatment of sleep disorders is an important part of Parkinson’s therapy and can significantly improve quality of life....…
View Post 5 min This content is machine translated Multiple sclerosis Avoiding the nocebo trap with natalizumab biosimilars Monoclonal antibodies such as natalizumab are indispensable for multiple sclerosis therapy. A first recently approved biosimilar is clinically equivalent, as studies have shown. Nevertheless, reservations are widespread in practice. Patients...…
View Post 5 min This content is machine translated Brain health News from the Swiss Brain Health Plan (SBHP) 2023-2033 The high burden of neurological and psychiatric diseases makes a national strategy and close interdisciplinary collaboration essential. The Swiss Brain Health Plan (SBHP) 2023-2033, a comprehensive initiative to promote brain...…
View Post 3 min This content is machine translated Friedreich's ataxia Treatment options have improved Friedreich’s ataxia is a hereditary neurodegenerative disease that is classically characterized by uncoordinated movements, postural and gait disorders, as well as balance and visual disorders. Subgroups of those affected also...…
View Post 16 min This content is machine translated Low-grade pediatric gliomas Consideration of the tumor microenvironment opens up new treatment options Low-grade gliomas are among the most common primary brain tumors in childhood and can affect patients for life, which is why early diagnosis involving the tumor microenvironment is of significant...… CME-Test
View Post 6 min This content is machine translated DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline Stroke prevention for atrial fibrillation 2025 Atrial fibrillation is the most important treatable risk factor for ischemic strokes in 2025 – and at the same time an area where precision makes all the difference. The major...…
View Post 8 min This content is machine translated New perspectives for clinics and research Ageing, cellular senescence and Parkinson’s disease Parkinson’s is one of the most common neurodegenerative diseases and continues to pose major challenges for neurology. It has long been clear that age is the decisive risk factor –...…
View Post 6 min This content is machine translated Migraine and vascular regulation CGRP-targeted migraine therapies for vascular risk patients Migraine is one of the most common neurological disorders and affects millions of people worldwide. With the development of CGRP-targeted therapies – monoclonal antibodies and Gepanten – the treatment of...…
View Post 6 min This content is machine translated Pediatric multiple sclerosis Early high efficacy as the key to improving prognosis Pediatric multiple sclerosis (POMS) is a rare but particularly challenging form of the disease. Children and adolescents with MS often experience more relapses, a greater lesion burden on MRI and...…
View Post 6 min This content is machine translated Diagnosis and treatment of neurological and psychiatric illnesses Precision Neurology Neuroscience has made a huge leap in knowledge in recent decades. New methods in genomics, epigenetics, proteomics, metabolomics, imaging and data integration make it possible to characterize diseases more precisely...…
